Qrem
The company develops and provides a 'Lab-in-a-box' technology called Qrem Cytokine for the production of Autologous Cytokine Rich Serum (ACRS) from a patient's own blood. This medical device and single-use kit allow healthcare professionals to obtain and administer regenerative therapies for musculoskeletal and dermatological pathologies directly in their clinics. The process automates the extraction of cytokines to stimulate tissue repair and reduce inflammation without the use of drugs.
Healthtech
Medical Devices
Biotechnology
Regenerative Medicine
Funding summary
- Total raised
- €1.0M
- Funding rounds
- 1
Investors in Qrem
Investors on record for Qrem. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Qrem?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors